177 related articles for article (PubMed ID: 33951758)
1. The assessment of circulating cell-free DNA as a diagnostic tool for breast cancer: an updated systematic review and meta-analysis of quantitative and qualitative ssays.
Guo Q; Hua Y
Clin Chem Lab Med; 2021 Aug; 59(9):1479-1500. PubMed ID: 33951758
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of cell-free DNA accuracy as diagnostic biomarker for prostate cancer: A systematic review and meta-analysis.
Chen C; Chen C; Sadeghi M
Biotechnol Appl Biochem; 2022 Apr; 69(2):749-766. PubMed ID: 33749048
[TBL] [Abstract][Full Text] [Related]
3. Value of circulating cell-free DNA analysis as a diagnostic tool for breast cancer: a meta-analysis.
Lin Z; Neiswender J; Fang B; Ma X; Zhang J; Hu X
Oncotarget; 2017 Apr; 8(16):26625-26636. PubMed ID: 28460452
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of analysis of cfDNA for detection of single nucleotide variants and copy number variants in breast cancer.
Yang X; Zhang K; Zhang C; Peng R; Sun C
BMC Cancer; 2019 May; 19(1):465. PubMed ID: 31101027
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic significance assessment of the circulating cell-free DNA in ovarian cancer: An updated meta-analysis.
Li B; Pu K; Ge L; Wu X
Gene; 2019 Sep; 714():143993. PubMed ID: 31330238
[TBL] [Abstract][Full Text] [Related]
6. Salivary biomarkers in breast cancer diagnosis: A systematic review and diagnostic meta-analysis.
Koopaie M; Kolahdooz S; Fatahzadeh M; Manifar S
Cancer Med; 2022 Jul; 11(13):2644-2661. PubMed ID: 35315584
[TBL] [Abstract][Full Text] [Related]
7. Detection of Circulating Cell-Free DNA to Diagnose Hepatocellular Carcinoma in Chinese Population: A Systematic Review and Meta-Analysis.
Aalami AH; Aalami F; Aliabadi EK; Amirabadi A; Sahebkar A
Curr Med Chem; 2023 Jun; ():. PubMed ID: 37349993
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic accuracy of circulating free DNA for the detection of KRAS mutation status in colorectal cancer: A meta-analysis.
Xie W; Xie L; Song X
Cancer Med; 2019 Mar; 8(3):1218-1231. PubMed ID: 30791218
[TBL] [Abstract][Full Text] [Related]
9. Analysis of circulating microRNA biomarkers for breast cancer detection: a meta-analysis.
Liu L; Wang S; Cao X; Liu J
Tumour Biol; 2014 Dec; 35(12):12245-53. PubMed ID: 25195131
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Accuracy of PIK3CA Mutation Detection by Circulating Free DNA in Breast Cancer: A Meta-Analysis of Diagnostic Test Accuracy.
Zhou Y; Wang C; Zhu H; Lin Y; Pan B; Zhang X; Huang X; Xu Q; Xu Y; Sun Q
PLoS One; 2016; 11(6):e0158143. PubMed ID: 27336598
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance of circulating tumor DNA as a minimally invasive biomarker for hepatocellular carcinoma: a systematic review and meta-analysis.
Li JJ; Lv Y; Ji H
PeerJ; 2022; 10():e14303. PubMed ID: 36348665
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of circulating free DNA for the detection of EGFR mutation status in NSCLC: a systematic review and meta-analysis.
Luo J; Shen L; Zheng D
Sci Rep; 2014 Sep; 4():6269. PubMed ID: 25201768
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of circulating cell-free DNA for hepatocellular carcinoma: a systematic review and meta-analysis.
Zhang J; Yuan Y; Gao S; Zhao X; Li H
Biomark Med; 2021 Feb; 15(3):219-239. PubMed ID: 33470842
[No Abstract] [Full Text] [Related]
14. Value of quantitative and qualitative analyses of circulating cell-free DNA as diagnostic tools for hepatocellular carcinoma: a meta-analysis.
Liao W; Mao Y; Ge P; Yang H; Xu H; Lu X; Sang X; Zhong S
Medicine (Baltimore); 2015 Apr; 94(14):e722. PubMed ID: 25860220
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Value of Concentration of Circulating Cell-Free DNA in Breast Cancer: A Meta-Analysis.
Yu D; Tong Y; Guo X; Feng L; Jiang Z; Ying S; Jia J; Fang Y; Yu M; Xia H; Shi L; Lou J
Front Oncol; 2019; 9():95. PubMed ID: 30881916
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of circulating cell-free DNA for renal cell carcinoma: a meta-analysis.
Li Y; Chen P; Chen Z
Transl Cancer Res; 2021 May; 10(5):2265-2276. PubMed ID: 35116544
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic role of microRNA-34a in breast cancer: a systematic review and meta-analysis.
Imani S; Zhang X; Hosseinifard H; Fu S; Fu J
Oncotarget; 2017 Apr; 8(14):23177-23187. PubMed ID: 28423566
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of cell-free DNA in thyroid cancer: A systematic review and meta-analysis.
Hou F; Sun XD; Deng ZY
Medicine (Baltimore); 2023 Feb; 102(7):e32928. PubMed ID: 36800605
[TBL] [Abstract][Full Text] [Related]
19. Staging/restaging performance of F18-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in breast cancer: A review and meta-analysis.
Lin CY; Lin CL; Kao CH
Eur J Radiol; 2018 Oct; 107():158-165. PubMed ID: 30292261
[TBL] [Abstract][Full Text] [Related]
20. CircRNAs as promising biomarker in diagnosis of breast cancer: An updated meta-analysis.
Chu M; Fang Y; Jin Y
J Clin Lab Anal; 2021 Sep; 35(9):e23934. PubMed ID: 34331339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]